A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and Vehicle

Completed · Phase 3

Conditions studied: Allergic Conjunctivitis

In brief

A Single-Center study to demonstrate the non-inferiority of EM-100 to Zaditor® in the treatment of ocular itching.

Key facts

Study ID

NCT03489941

Run by

Bausch & Lomb Incorporated

People needed

65

Starts

2018-04-07

Expected to finish

2018-04-29

Last updated by the study team

2023-06-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• be at least 18 years old
• have a positive history of allergic conjunctivitis and positive skin test reaction to allergens
• be willing to avoid disallowed medications for the appropriate washout period and throughout the trial
• be willing to avoid contact lens use
• be willing to have a pregnancy test
• must be able to read an eye chart from 10 feet away

You may not qualify if…

• must not have any allergies to the study medications
• must not have any ocular or non ocular condition that investigator feels will interfere with study parameters
• must not have used an investigational drug or device in the past 30 days or currently be enrolled in another investigational trial

Where it is running

• Total Eye Care, PA — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.